For a pharmaceutical manufacturer to legally make and sell drugs, it must apply for and receive an approval from the Food and Drug Administration (FDA). Sage Pharmaceuticals failed to do this, according to a recent lawsuit filed against the company by the Department of Justice (DOJ), on behalf of the FDA.
According to a press release issued by the DOJ, Sage violated the Federal Food, Drug and Cosmetic Act (FDCA) by selling drugs that were not approved or properly labeled.
A History of Legal Troubles for Sage
This is not Sage’s first run-in with the federal government. The DOJ successfully sought an injunction against the company for selling drugs without approval in 2000. Since then, investigations have revealed that company continues to skirt the law in its production and sale of pharmaceuticals, and the DOJ wants it to “cease all receiving, processing, manufacturing, preparing, packaging, labeling, holding and distributing activities until they comply with applicable FDA regulations.”
There are reasons for the massive regulations that govern the pharmaceutical industry. When drug companies rush drugs through development, commission studies to prove their “safety” and release dangerous drugs into the marketplace, they risk injuring or killing millions of consumers. We remind our readers that there is strength in numbers: through class action lawsuits, you can join other similarly injured victims and seek justice as one body. Call 888-841-9623 to learn more.
Tip of the Week: Before taking a drug, check the FDA’s website to learn about its approval status and any recalls or warnings.
Zoll, Kranz & Borgess, LLC – class action attorneys